Literature DB >> 12482556

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.

Pierre-Yves Scarabin1, Dominique Arveiler, Philippe Amouyel, Carla Dos Santos, Alun Evans, Gérald Luc, Jean Ferrières, Irène Juhan-Vague.   

Abstract

The incidence of coronary heart disease is higher in Northern Ireland than in France. These differences have not been adequately explained. We have investigated the associations of plasma fibrinogen concentration and factor VII activity with the incidence of coronary heart disease in a prospective cohort study involving 10600 men aged 50-59 living in four regions (Lille, Strasbourg, and Toulouse in France, Belfast in Northern Ireland). Baseline fibrinogen and factor VII were measured in 9489 men free of coronary heart disease at entry (7167 in France and 2322 in Northern Ireland). Over 5 years of follow-up, 161 participants developed myocardial infarction (MI) or coronary death (100 in France and 61 in Belfast) and 151 developed angina pectoris (94 in France and 57 in Belfast). The risk of future coronary events was 1.9 times higher in Belfast than in France (95% confidence interval: 1.5-2.4). Baseline mean levels of fibrinogen were significantly higher in Belfast than in France and they were higher in participants who experienced coronary events compared with those who did not in both countries. The age-adjusted relative risk of coronary heart disease associated with a rise of one standard deviation in fibrinogen level was 1.56 (95% confidence interval: 1.29-1.95, P<0.0001) in the whole cohort. This association remained significant after adjustment for other cardiovascular risk factors (relative risk:1.36; 95% confidence interval: 1.14-1.68; P<0.0001). There was no clear geographical variation in factor VII and no significant association between factor VII levels and the risk of coronary events was observed. Classic risk factors explained 25% of the excess risk of coronary heart disease in Belfast compared with France, while fibrinogen alone accounted for 30%. These findings add to the epidemiological evidence that elevated fibrinogen is a major risk factor for coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482556     DOI: 10.1016/s0021-9150(02)00309-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

Review 1.  The French paradox: lessons for other countries.

Authors:  Jean Ferrières
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

2.  Prothrombotic gene polymorphisms and plasma factors in young North Indian survivors of acute myocardial infarction.

Authors:  Rupinder Kaur Dogra; Reena Das; Jasmina Ahluwalia; Rohit Manoj Kumar; K K Talwar
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

Review 3.  Deciphering the nuclear bile acid receptor FXR paradigm.

Authors:  Salvatore Modica; Raffaella M Gadaleta; Antonio Moschetta
Journal:  Nucl Recept Signal       Date:  2010-11-19

4.  Ideal Cardiovascular Health and Incident Cardiovascular Disease: Heterogeneity Across Event Subtypes and Mediating Effect of Blood Biomarkers: The PRIME Study.

Authors:  Bamba Gaye; Muriel Tafflet; Dominique Arveiler; Michèle Montaye; Aline Wagner; Jean-Bernard Ruidavets; Frank Kee; Alun Evans; Philippe Amouyel; Jean Ferrieres; Jean-Philippe Empana
Journal:  J Am Heart Assoc       Date:  2017-10-17       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.